The Association of Biotechnology Companies BioForum launches the #polishbiotech online database as the largest association of biotech companies in Poland.
We are the first point of contact for entrepreneurs in the biotechnology industry and we constantly support the Polish biotechnology community 👩🔬 👨🔬
SIGN UP HERE 👇👇👇
"*" indicates required fields
Eli Lilly Polska Sp. z o.o.
+ business areaBioPharma R&D+Services
+ annual revenue
2020 - 67,200,000 PLN
2021 - 66,500,000 PLN
2022 - 80,000,000 PLN
2023 - 105,900,000 PLN
+ workforce (estimated if not reported)
2024 - 136
+ depreciation & amortization
2020 - 631,900 PLN
2021 - 561,700 PLN
2022 - 527,100 PLN
2023 - 856,100 PLN
Eli Lilly Polska is a bio-pharmaceutical company focusing on diabetes, neuroscience, oncology, cardiology, and other therapeutic areas. It combines innovation with patient care and provides advanced medicines improving patients’ quality of life.